XML 22 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance, value at Jul. 25, 2015 $ 507,200 $ 11,127 $ 71,004 $ (1,198) $ 426,267
Beginning balance, shares at Jul. 25, 2015   33,381,779      
Increase (Decrease) in Stockholders' Equity          
Stock options exercised, value 2,745 $ 71 2,674    
Stock options exercised, shares   212,619      
Stock-based compensation, value 16,850 $ 1 16,849    
Stock-based compensation, shares   3,015      
Issuance of restricted stock, net of tax withholdings, value (12,604) $ 111 (12,715)    
Issuance of restricted stock, net of tax withholdings, shares   334,475      
Repurchase of common stock, value $ (169,997) $ (837) (152,033)   (17,127)
Repurchase of common stock, shares (2,511,578) (2,511,578)      
Tax benefits from stock-based compensation $ 13,003   13,003    
Equity component of 0.75% convertible senior notes due 2021, net 112,554   112,554    
Sale of warrants 74,690   74,690    
Purchase of convertible note hedges (115,818)   (115,818)    
Other comprehensive loss (76)     (76)  
Net income 128,740       128,740
Ending balance, value at Jul. 30, 2016 557,287 $ 10,473 10,208 (1,274) 537,880
Ending balance, shares at Jul. 30, 2016   31,420,310      
Increase (Decrease) in Stockholders' Equity          
Stock options exercised, value 1,449 $ 34 1,415    
Stock options exercised, shares   102,831      
Stock-based compensation, value 20,805 $ 1 20,804    
Stock-based compensation, shares   2,847      
Issuance of restricted stock, net of tax withholdings, value (10,767) $ 92 (10,859)    
Issuance of restricted stock, net of tax withholdings, shares   274,303      
Repurchase of common stock, value $ (62,909) $ (238) (19,861)   (42,810)
Repurchase of common stock, shares (713,006) (713,006)      
Tax benefits from stock-based compensation $ 8,385   8,385    
Other comprehensive loss 116     116  
Net income 157,217       157,217
Ending balance, value at Jul. 29, 2017 671,583 $ 10,362 10,092 (1,158) 652,287
Ending balance, shares at Jul. 29, 2017   31,087,285      
Increase (Decrease) in Stockholders' Equity          
Stock options exercised, value 745 $ 18 727    
Stock options exercised, shares   52,553      
Stock-based compensation, value 13,277 $ 1 13,276    
Stock-based compensation, shares   1,492      
Issuance of restricted stock, net of tax withholdings, value (12,581) $ 81 (7,985)   (4,677)
Issuance of restricted stock, net of tax withholdings, shares   244,339      
Repurchase of common stock, value $ (16,875) $ (67) (9,940)   (6,868)
Repurchase of common stock, shares (200,000) (200,000)      
Tax benefits from stock-based compensation $ 7,800        
Other comprehensive loss 12     12  
Net income 68,835        
Ending balance, value at Jan. 27, 2018 $ 724,996 $ 10,395 6,170 (1,146) 709,577
Ending balance, shares at Jan. 27, 2018 31,185,669 31,185,669      
Increase (Decrease) in Stockholders' Equity          
Stock options exercised, value $ 871 $ 27 844    
Stock options exercised, shares   82,235      
Stock-based compensation, value 20,187 $ 1 20,186    
Stock-based compensation, shares   3,122      
Issuance of restricted stock, net of tax withholdings, value (4,657) $ 54 (4,711)    
Issuance of restricted stock, net of tax withholdings, shares   159,005      
Tax benefits from stock-based compensation 200        
Other comprehensive loss (136)     (136)  
Net income 62,907        
Ending balance, value at Jan. 26, 2019 $ 804,168 $ 10,477 $ 22,489 $ (1,282) $ 772,484
Ending balance, shares at Jan. 26, 2019 31,430,031 31,430,031